Back
Plus Therapeutics Quote, Financials, Valuation and Earnings
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
PSTV
Plus Therapeutics
Last Price:
1.15
Seasonality Move:
2.43%
7 Day Trial
ALL ACCESS PASS
$
7
Market Direction Doesn't Matter Anymore
See the next Cash Flow Opportunity here.Plus Therapeutics Price Quote
$1.15
-0.02 (-9.45%)
(Updated: December 17, 2024 at 5:29 AM ET)
Plus Therapeutics Key Stats
Sell
41
Plus Therapeutics (PSTV)
is a Sell
Day range:
$1.12 - $1.28
52-week range:
$1.12 - $2.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.28
P/B ratio:
0%
Volume:
69.6K
Avg. volume:
115.6K
1-year change:
-38.74%
Market cap:
$6.9M
Revenue:
$0
EPS:
$-2.53
How Much Does Plus Therapeutics Make?
Data Unavailable
Is Plus Therapeutics Growing As A Company?
Data Unavailable
Plus Therapeutics Stock Price Performance
-
Did Plus Therapeutics Stock Go Up Last Month?
Plus Therapeutics share price went up by 0% last month -
Did PSTV's Share Price Rise Over The Last Year?
PSTV share price fell by -38.74% over the past 1 year
What Is Plus Therapeutics 52-Week High & Low?
-
What Is Plus Therapeutics’s 52-Week High Share Price?
Plus Therapeutics has traded as high as $2.67 over the past 52 weeks -
What Is Plus Therapeutics’s 52-Week Low Share Price?
Plus Therapeutics has traded as low as $1.12 over the past 52 weeks
Plus Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Plus Therapeutics?
-
How Much Debt Does Plus Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Plus Therapeutics Have?
Cash and short term investments quarterly total is $4.8M -
What Is Plus Therapeutics’s Book Value Per Share?
Book value per share is -0.88
Is Plus Therapeutics Cash Flow Positive?
-
What Is PSTV Cash Flow From Operations?
Cash flow from operations (TTM) is -$11.2M -
What Is Plus Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.7M -
What Is Plus Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.2M
Plus Therapeutics Return On Invested Capital
Data Unavailable
Plus Therapeutics Earnings Date & Stock Price
-
What Is Plus Therapeutics's Stock Price Today?
A single share of PSTV can be purchased today for 1.17 -
What Is Plus Therapeutics’s Stock Symbol?
Plus Therapeutics trades on the nasdaq under the ticker symbol: PSTV -
When Is Plus Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Plus Therapeutics is scheduled on December 17, 2024 -
When Is PSTV's next ex-dividend date?
Plus Therapeutics's next ex-dividend date is December 17, 2024 -
How To Buy Plus Therapeutics Stock?
You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Plus Therapeutics Competitors
-
Who Are Plus Therapeutics's Competitors?
Below is a list of companies who compete with Plus Therapeutics or are related in some way:
Plus Therapeutics Dividend Yield
-
What Is PSTV Dividend Yield?
Plus Therapeutics’s dividend yield currently is 0% -
What Is Plus Therapeutics’s Payout Ratio?
Plus Therapeutics’s payout ratio is 0% -
When Did Plus Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 17, 2024 -
What Is Plus Therapeutics’s Dividend Per Share?
Plus Therapeutics pays a dividend of $0.00 per share
Plus Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 34.22% |
| Revenue: | 0% | 28.03% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 15.75 |
| Upside from Last Price: | 1246.15% |